Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Both tirzepatide and semaglutide reduce appetite and improve blood sugar control, but they activate different hormone receptors in your brain and gut. Clinical trials show tirzepatide users lose more weight on average than semaglutide users, though individual results vary widely based on genetics, lifestyle, and metabolism. PlexusDx helps you determine which medication aligns with your body's unique peptide pathways.
How Tirzepatide and Semaglutide Work Differently
Semaglutide activates only the GLP-1 receptor, a hormone sensor that tells your brain you are full and slows stomach emptying. Tirzepatide activates both the GLP-1 and GIP receptors, creating a dual-action effect that signals fullness through two separate biological channels simultaneously. This dual-receptor activation means tirzepatide engages more of your body's natural appetite-suppression system, which helps explain why weight loss outcomes often differ between the two medications.
The GIP receptor is particularly important for controlling how your body processes and stores glucose and fat. When activated alongside GLP-1, the GIP pathway can enhance insulin sensitivity and reduce hunger signals more powerfully than GLP-1 alone. Research into peptide-pathway genetics shows that some people's bodies respond more robustly to dual activation, while others may see comparable results from single-receptor therapy.
Weight Loss Results: What Clinical Trials Show
In head-to-head weight loss studies, tirzepatide users achieved an average of 21 percent body weight reduction over 68 weeks, compared to approximately 15 percent for semaglutide users at the highest doses. These figures represent approximately 20 to 25 pounds more weight loss for a 200-pound person taking tirzepatide over the same timeframe. However, individual variation is substantial—some semaglutide users lose weight at rates matching tirzepatide users, while some tirzepatide users lose less than average.
Factors affecting your personal weight loss include starting weight, adherence to dosing schedules, diet quality, physical activity level, sleep duration, and stress management. Genetic variations in your GLP1R, GIPR, FTO, and MC4R genes influence how strongly you respond to each medication. PlexusDx's Precision Peptide Genetic Test maps 14 metabolic pathways across 49 peptides to identify which compounds may produce stronger results for your unique biology.
Comparing Side Effects and Tolerability Between the Two
Both medications commonly cause nausea, constipation, and reduced appetite during the dose-escalation phase—these effects typically decrease after 2 to 4 weeks as your body adapts. Tirzepatide users report slightly higher rates of nausea in early studies, though this difference narrows over time and does not always translate to treatment discontinuation. Injection-site reactions are rare with either compounded medication from licensed 503A pharmacies when proper injection technique is used.
Some users experience stomach pain, vomiting, or diarrhea, especially if they consume high-fat foods while on treatment. These gastrointestinal side effects are generally mild to moderate and resolve without intervention. PlexusDx's clinical team can adjust your medication choice or dose based on tolerability feedback, allowing you to find the right balance between efficacy and comfort.
Choosing Between Tirzepatide and Semaglutide at PlexusDx
PlexusDx offers compounded tirzepatide injection starting at $249 per month, plus access to semaglutide injection, oral tirzepatide, oral semaglutide, and combination GLP-Squared formulations. Your dose may need to go up over time to maintain weight loss as your body adapts, but your price remains flat—no surprise increases as you progress through your treatment plan. All medications ship to all 50 states without insurance requirements or membership fees, and they are HSA/FSA eligible.
After your first month of treatment, you may add the Precision Peptide Genetic Test for $99 to map your peptide pathways and identify which medication your genetics predict will work best. This test examines 150+ genetic insights across 14 metabolic pathways, helping PlexusDx clinicians personalize your therapy more precisely than standard approaches. Whether tirzepatide or semaglutide is your best choice depends on your genetic profile, weight loss goals, side effect tolerance, and personal preference—PlexusDx guides you through that decision with evidence-based medical support.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will I lose more weight on tirzepatide than semaglutide?
On average, tirzepatide users lose about 6 percent more body weight than semaglutide users over comparable timeframes, but individual results vary significantly based on genetics, adherence, and lifestyle. PlexusDx's Precision Peptide Genetic Test can help identify whether your body's GIPR and GLP1R expression suggests you'll respond better to tirzepatide's dual-receptor mechanism. A consultation with PlexusDx clinicians will help determine which medication aligns best with your metabolism and goals.
How does the GIP receptor differ from the GLP-1 receptor?
The GLP-1 receptor signals fullness and slows digestion, while the GIP receptor enhances insulin release and reduces glucose production in the liver. When both receptors are activated together by tirzepatide, you get amplified hunger suppression and better metabolic control compared to GLP-1 activation alone. This dual action is why some patients achieve faster and more sustained weight loss with tirzepatide, though genetic variation means response varies.
What is PlexusDx's pricing for tirzepatide, and does it change with dose increases?
PlexusDx compounded tirzepatide injection starts at $249 per month flat—your price does not increase as your dose increases over time. This flat-rate model means you can safely escalate your dose to the level your body needs without facing unexpected cost jumps. All medications are HSA/FSA eligible, and PlexusDx serves all 50 states without insurance or membership requirements.
Are there serious side effects I should watch for?
Serious side effects like acute pancreatitis or severe dehydration are rare with both medications when used as directed under medical supervision. Common side effects—nausea, constipation, and appetite suppression—typically diminish after initial weeks. PlexusDx clinicians monitor your response and can adjust your medication or dose if side effects become problematic, ensuring your treatment remains safe and tolerable.
How does the Precision Peptide Genetic Test help me choose between tirzepatide and semaglutide?
PlexusDx's Precision Peptide Genetic Test ($99 after your first month) examines key variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 across 14 metabolic pathways and 150+ genetic insights. These results predict how strongly your body will respond to each medication's mechanism, helping PlexusDx clinicians recommend tirzepatide, semaglutide, or combination therapy most likely to deliver your weight loss goals. Personalized genetic guidance removes guesswork from treatment selection.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Where Can I Give My Ozempic Shot?
Where Should I Inject My Wegovy? A Comprehensive Guide